OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program

Richard B. Lipton, Noah L. Rosen, Jessica Ailani, Ronald E. Degryse, Patrick J. Gillard, Sepideh F. Varon

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program'. Together they form a unique fingerprint.

Medicine & Life Sciences